These success, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the thought of concentrating on ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-connected disorders. These results suggest that conolidine https://enricox161the6.wikikarts.com/user